Skip to main content

Branded

  • Study finds men on long-acting opioids have lower testosterone

    OAKLAND, Calif. — Men taking long-acting medications for chronic pain are almost five times more likely to have low testosterone levels, according to a new study by Kaiser Permanente.

    The study, which the healthcare system called the first to show a significant difference in risk between short-acting and long-acting opioids, appeared in The Clinical Journal of Pain.

  • NCPDP releases updated acetaminophen white paper

    SCOTTSDALE, Ariz. — A standards-development organization for the pharmacy services industry has updated a white paper on protecting consumers and patients from accidental overdoses of the painkiller acetaminophen.

    The NCPDP announced the updated white paper, "NCPDP Recommendations for Improved Prescription Container Labels for Medicines Containing Acetaminophen Version 1.1."

  • FDA panel recommends approval for Boehringer Ingelheim COPD drug

    RIDGEFIELD, Conn. — A panel of Food and Drug Administration experts has recommended approval for an experimental drug made by Boehringer Ingelheim for chronic obstructive pulmonary disease, the drug maker said.

  • FDA approves Genzyme drug for rare cholesterol disorder

    SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug for treating a rare cholesterol disorder, the agency said.

    The FDA announced the approval of Kynamro (mipomersen sodium), made by Genzyme for the treatment of homozygous familial hypercholesterolemia, or HoFH. Kynamro has been approved as an orphan drug, a designation the FDA gives to drugs that treat diseases affecting fewer than 200,000 people.

  • Costco offers Aetna insurance to California members

    WALNUT CREEK, Calif. — Aetna is offering individual health insurance plans to Costco members in California, the health insurer said.

    The Costco Personal Health Insurance program includes five plans and offers broad medical benefits, dental options and a large network of doctors and hospitals. The program also is available to members of the club retailer in Arizona, Connecticut, Georgia, Illinois, Michigan, Nevada, Pennsylvania, Texas and Virginia. Aetna plans to expand the program to other markets in the coming months.

  • Estrogen patch, described as smallest, available at pharmacies

    NEW YORK — A patch for treating menopause that the manufacturer calls the smallest is now available.

    Noven Pharmaceuticals announced the availability of Minivelle (estradiol) transdermal system in pharmacies. The patch, which the Food and Drug Administration approved in October 2012, is designed for treating hot flashes and night sweats in women with menopause.

    The patch has a surface area nearly the same as a dime at its lowest strength of 0.0375 mg-per-day and is 34% smaller than Noven's Vivelle-Dot patch, the company said.

  • New York Times: Battle against biogenerics is on

    NEW YORK — The battle against biogenerics is on, noted a report published in The New York Times Tuesday.  As many as eight states have introduced legislation that would restrict generic competition of biological pharamceuticals so far this year and one, the Virginia House of Delegates, already passed such a measure by a 91-to-6 vote. 

  • Sanofi's Auvi-Q epinephrine injection now available

    BRIDGEWATER, N.J. — Sanofi announced today that Auvi-Q (epinephrine injection, USP) is now available in U.S. retail pharmacies nationwide with a prescription from a healthcare provider.

     

X
This ad will auto-close in 10 seconds